Results 111 to 120 of about 5,356 (175)

Advances in Reperfusion Therapy and Cytoprotection for Acute Ischemic Stroke. [PDF]

J Cardiovasc Dev Dis
Li Z, Wang C.
europepmc   +1 more source

Evaluation of antioxidant and anti-inflammatory potential and <i><u>in silico</u></i> tyrosinase binding interactions of edaravone derivatives. [PDF]

J Enzyme Inhib Med Chem
Kulkarni NV, S A A, S A I, Senthurpandi D, Bojilov DG, Manolov SP, Ivanov II, Al-Otaibi JS, Mary YS.   +8 more
europepmc   +1 more source

Therapeutic Potential of Edaravone for Neuroprotection Following Global Cerebral Hypoxia. [PDF]

Int J Mol Sci
Busse JF, Frai J, Hamacher LI, Matschke V, Theiss C, Weber T, Herzog-Niescery J, Stahlke S.   +7 more
europepmc   +1 more source

Cost-effectiveness of edaravone dexborneol sublingual tablet versus concentrated solution for injection for the treatment of acute ischemic stroke in China. [PDF]

Front Pharmacol
Xie F, Lu Y, Yang Z, Zhang Y, Bao Y, Lu Y.   +5 more
europepmc   +1 more source

Association between intracranial arterial stenosis severity and recurrent stroke risk in elderly ischemic stroke patients. [PDF]

Front Neurol
Tao Z, Guo H, Liu Y, Yin JB, Qiang HH, Lu H.   +5 more
europepmc   +1 more source

Retraction to: Edaravone alleviates lung damage in mice with hypoxic pulmonary hypertension by increasing nitric oxide synthase 3 expression. [PDF]

Korean J Physiol Pharmacol
Zheng W, Li T, Wei J, Yan Y, Yang S.
europepmc   +1 more source